Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis

Background: Risk of natalizumab-related progressive multifocal leukoencephalopathy is associated with the presence of anti-JC-virus (JCV) antibodies. Objective: To investigate the impact of disease-modifying treatments (DMT) on the longitudinal evolution of anti-JCV antibody index. Methods: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegen, Harald, Walde, Janette, Bsteh, Gabriel, Auer, Michael, Wurth, Sebastian, Zinganell, Anne, Di Pauli, Franziska, Deisenhammer, Florian, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209669/
https://www.ncbi.nlm.nih.gov/pubmed/30410486
http://dx.doi.org/10.3389/fimmu.2018.02435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209669/
https://www.ncbi.nlm.nih.gov/pubmed/30410486
http://dx.doi.org/10.3389/fimmu.2018.02435

Ejemplares similares